Table 2 Treatment and outcomes among the fully vaccinated, partially vaccinated, and unvaccinated hospitalized COVID-19 patients
Complication | No. (%) | p value | ||
|---|---|---|---|---|
Unvaccinated (n = 224) | Partially vaccinated (n = 29) | Fully vaccinated (n = 88) | ||
Intubation/Mechanical ventilation (n = 42) | 34 (15.2%) | 6 (20.7%) | 2 (2.3%) | 0.003 |
Intensive Care Unit admission (n = 47) | 38 (17%) | 5 (17.2%) | 4 (4.5%) | 0.01 |
Septic shock (n = 29) | 24 (10.7%) | 3 (10.3%) | 2 (2.3%) | 0.05 |
Acute Respiratory Distress Syndrome (n = 23) | 21 (9.4%) | 1 (3.4%) | 1 (1.1%) | 0.03 |
Acute Kidney Injury (n = 84) | 61 (27.2%) | 7 (24.1%) | 16 (18.2%) | 0.2 |
Renal Replacement Therapy (n = 8) | 5 (2.2%) | 1 (3.4%) | 2 (2.3%) | 0.9 |
Any Arrhythmia (n = 30) | 22 (9.8%) | 2 (6.9%) | 6 (6.8%) | 0.7 |
Atrial arrythmia (n = 26) | 18 (8.0%) | 2 (6.9%) | 6 (6.8%) | 0.9 |
Steroids given (n = 222) | 162 (72.3%) | 19 (65.5%) | 41 (46.6%) | < 0.001 |
Remdesivir given (n = 108) | 81 (36.2%) | 13 (44.8%) | 14 (15.9%) | < 0.001 |
Interleukin-6 Inhibitor given (n = 30) | 25 (11.2%) | 3 (10.3%) | 2 (2.3%) | 0.04 |
Readmission within 30 days (n = 22) | 12 (6.5%) | 1 (3.8%) | 9 (10.6%) | 0.4 |
Death (n = 46) | 40 (17.9%) | 3 (10.3%) | 3 (3.4%) | 0.003 |